Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats.
This study was designed to compare the effects of dietary supplementation with nondigestible carbohydrates, differing in fermentability by colonic bacteria, on hepatic steatosis in growing obese Zucker rats. Male Zucker fa/fa rats were divided into three groups: a control group that received the basal diet, a fructan group that received 10 g highly fermented Synergy 1/100 g diet and a cellulose group that received 10 g poorly fermented Vivapur Microcrystalline cellulose/100 g diet. Rats consuming fructan had a lower energy intake, a lower body weight and less triacylglycerol accumulation in the liver as assessed in vivo by nuclear magnetic resonance (NMR) spectroscopy, and ex vivo by biochemical and histochemical analysis compared with the control and/or cellulose groups. The high fermentation of fructans compared with cellulose was reflected by greater cecal contents and by a twofold greater propionate concentration in the portal vein of rats fed fructan compared with those fed cellulose. By measuring the capacity of hepatocytes isolated from liver of Zucker rats to synthesize triglycerides or total lipids from different precursors, we showed that propionate, at the concentrations measured in the portal vein of rats treated with fructan, selectively decreased the incorporation of acetate into total lipids, a phenomenon that could contribute, along with the lower energy intake, to less triglyceride accumulation in the liver of obese Zucker rats fed dietary fructans.
Daubioul
Catherine
C
Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, 7369 School of Pharmacy, Université catholique de Louvain, B-1200 Brussels, Belgium.
Rousseau
Nicolas
N
Demeure
Roger
R
Gallez
Bernard
B
Taper
Henryk
H
Declerck
Barbara
B
Delzenne
Nathalie
N
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002432:Cecum / Q000737:chemistry; D002482:Cellulose / Q000008:administration & dosage*; D019587:Dietary Supplements; D004195:Disease Models, Animal; D002149:Energy Intake / Q000187:drug effects; D005234:Fatty Liver / Q000378:metabolism* / Q000473:pathology; D005285:Fermentation; D005630:Fructans / Q000008:administration & dosage*; D022781:Hepatocytes / Q000378:metabolism; D008099:Liver / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009765:Obesity / Q000378:metabolism*; D011169:Portal Vein; D011422:Propionates / Q000032:analysis; D051381:Rats; D011924:Rats, Zucker; D013997:Time Factors; D014280:Triglycerides / Q000378:metabolism*
D005630:Fructans; D011422:Propionates; D014280:Triglycerides; D002482:Cellulose